Hong Kong, China

Yu Chen

This inventor holds 1 USPTO granted patent. Top assignee: The Hong Kong University of Science and Technology. Active years: 2025.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Yu Chen. Retrieved from https://idiyas.com/inventor/yu-chen-z4x0xxma

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

Average Co-Inventor Count = 6.0

ph-index = 1


Company Filing History:


Years Active: 2025

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Yu Chen: Innovator in Alzheimer's Disease Diagnosis

Introduction: Yu Chen is a prominent inventor based in Hong Kong, CN. He has made significant contributions to the field of genetics, particularly in the diagnosis of Alzheimer's disease. His innovative work has the potential to improve diagnostic methods and treatment options for this debilitating condition.

Latest Patents: Yu Chen holds 1 patent related to genetic variants for the diagnosis of Alzheimer's disease. This patent provides genetic markers associated with Alzheimer's disease (AD), along with diagnostic and treatment methods for AD, and kits for diagnosing the disease. His research is crucial in advancing the understanding and management of Alzheimer's disease.

Career Highlights: Yu Chen is affiliated with The Hong Kong University of Science and Technology, where he conducts research and develops innovative solutions in the field of genetics. His work has garnered attention for its potential impact on healthcare and disease management.

Collaborations: Yu Chen has collaborated with notable colleagues, including Nancy Yuk-Yu Ip and Kit Yu Fu. These partnerships enhance the research efforts and contribute to the advancement of knowledge in the field.

Conclusion: Yu Chen's contributions to the diagnosis of Alzheimer's disease through his innovative patent highlight his role as a key figure in the field of genetics. His work not only advances scientific understanding but also holds promise for improving patient outcomes in the future.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…